Department of Bone and Soft Tissue ,Henan Cancer Hospital
Zhengzhou, Henan, China
NCT Number: NCT05616195
To report the patients who underwent 3D-printed bone prosthesis replacement in Henan Cancer Hospital in the next 10 years, and collect the postoperative complications and limb function of these patients.
Trial opening soon.
Get NotifiedAll sexes
Observational
Zhengzhou, Henan, China
To report the patients who underwent 3D-printed bone prosthesis replacement in Henan Cancer Hospital in the next 10 years. The basic data, treatment methods, postoperative complications and limb function of these patients were collected.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Men and women of all ages are welcome.
Pathologically confirmed in our hospital as a subtype of malignant tumor.
He received 3D printed bone prosthesis replacement in our hospital.
Exclusion criteria
Not applicable.
To report the postoperative complications and limb function of patients who underwent 3D-printed bone prosthesis replacement in Henan Cancer Hospital.
Time frame: From surgery to 24 months after surgery
Complications were collected from patients who underwent 3D-printed bone prosthesis replacement surgery.
Time frame: Patients were enrolled until 24 months after surgery
Limb function was assessed using the Musculoskeletal Oncology Society (MSTS) scoring scale for seven items, namely movement, pain, stability, deformity, strength, functional activity, and emotional receptiveness. The highest possible score is 35, with 5 points allocated to each project.
Henan Cancer Hospital
Other Gov
Application of 3D Printed Bone Prosthesis in Limb Salvage Surgery for Bone Tumors: a Single-center, Real-world Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06810388
Malignant Tumor, Neoplasms
View Trial DetailsNCT05616182
Malignant Tumor, Neoplasms
Zhengzhou, Henan, China
View Trial DetailsNCT04793672
Malignant Tumor, Neoplasms
Hangzhou, Zhejiang, China
View Trial DetailsNCT05781555
Malignant Tumor, Neoplasms
Jerusalem, Israel
View Trial Details